Can-Fite BioPharma Ltd.
CANF · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $11,951 | $16,845 | $13,752 | $16,957 |
| - Cash | $6,454 | $6,454 | $4,825 | $4,825 |
| + Debt | $90 | $90 | $104 | $104 |
| Enterprise Value | $5,587 | $10,481 | $9,031 | $12,236 |
| Revenue | $101 | $101 | $179 | $179 |
| % Growth | 0% | -43.6% | 0% | – |
| Gross Profit | $101 | $101 | $179 | $179 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$2,438 | -$2,438 | -$2,015 | -$2,015 |
| % Margin | -2,413.4% | -2,413.4% | -1,125.7% | -1,125.7% |
| Net Income | -$2,438 | -$2,438 | -$1,961 | -$1,961 |
| % Margin | -2,413.9% | -2,413.9% | -1,095.5% | -1,095.5% |
| EPS Diluted | -0.21 | -0.21 | -0.24 | -0.24 |
| % Growth | 0% | 12.5% | 0% | – |
| Operating Cash Flow | -$2,376 | -$2,376 | -$1,801 | -$1,801 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$2,377 | -$2,377 | -$1,801 | -$1,801 |